The board approved the un-audited financial results for the quarter and half year ended on 30-09-2025 in the meeting held today on 08-11-2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shentracon Chemicals reported zero operating revenue in Q2 FY26 (quarter ended Sept 30, 2025) and posted a loss of ₹48.34 lakh, driven largely by an exceptional item of ₹47.20 lakh. For the half year, the company swung to a small profit of ₹5.93 lakh against a loss of ₹7.36 lakh in the year-ago period, helped by ₹12 lakh in other income. The balance sheet is severely stressed, with negative total equity of ₹233.57 lakh (other equity at -₹677.38 lakh) against non-current borrowings of ₹303 lakh. Cash from operations was negative at ₹41.13 lakh for H1 FY26. Statutory auditor MARK & Co. issued a clean limited review report with no qualifications or emphasis of matter.
The negative net worth (liabilities exceed assets) and ongoing cash burn point to serious solvency stress, even though the auditor did not raise a going-concern flag. For shareholders, this is a small, financially distressed micro-cap where the headline H1 profit masks deep balance-sheet weakness—approach with extreme caution.